Home / Import refusals / 1FX-3440822-9/20002/6

FDA Import Refusal 1FX-3440822-9/20002/6 — Glaxo-Smithkline

Glaxo-Smithkline — FEI 3004725625

The FDA refused shipment 1FX-3440822-9/20002/6 from Glaxo-Smithkline (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,75

Refusal Details

Date
Aug 13, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
66VDB99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
118,75

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.